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High glucose alters the response of mesangial cell protein ki- recognized that high glucose is the principal pathogenic
nase C isoforms to endothelin-1. factor triggering excessive growth, particularly hypertro-
Background. High glucose causes glomerular mesangial phy, and accumulation of extracellular matrix. The ef-growth and increased matrix synthesis contributing to diabetic
fects of high glucose on glomerular mesangial cell signal-glomerulopathy. Our purpose was to determine if high glucose
ing leading to increased expression of the early responsealters endothelin-1 (ET-1) or platelet-derived growth factor-B
activation of mesangial cell diacylglycerol-sensitive protein ki- genes c-fos and c-jun occur within hours to days [1, 2].
nase C (PKC) isoforms and subsequent stimulation of mitogen- Substantial evidence supports a role for protein kinase
activated protein kinase (MAPK; p42, p44).
C (PKC) contributing to the high-glucose–induced earlyMethods. Rat mesangial cells in primary culture were growth
signaling events causing increased extracellular matrixarrested for 48 hours in glucose 5.6 mm (NG) or 30 mm (HG).
PKC-a, PKC-d, and PKC-e translocation from the cytosol-to- accumulation by cultured glomerular mesangial cells [3,
membrane and cytosol-to-particulate (cytoskeleton, nucleus) 4] and by cells of glomeruli isolated from diabetic rats
cellular fractions were measured by immunoblot using isoform- [5]. One mechanism may be the enhanced de novo syn-specific monoclonal antibodies. PKC isoforms were visualized
thesis of diacylglycerol (DAG) in the presence of raisedalso by confocal immunofluorescence microscopy. MAPK acti-
intracellular glucose [6], which in turn activates DAG-vation was measured by immunoblot using phospho-MAPK
antibody and by detection of Elk-1 fusion protein phosphoryla- sensitive PKC isoforms. The exact role of specific DAG-
tion following phospho-MAPK immunoprecipitation. sensitive PKC isoforms in mediating the effects of high
Results. In NG, ET-1 stimulated cytosol-to-membrane trans- glucose in mesangial cells is unknown.location of PKC-d and PKC-e but not PKC-a. In HG, the pattern
In vivo, mesangial cells are exposed to peptide growthof ET-1–stimulated PKC-d and PKC-e changed to a cytosol-to-
factors, many of which signal, in part, through PKC-particulate distribution, which was confirmed by confocal immu-
nofluorescence imaging. Platelet-derived growth factor-B did dependent pathways. The increased production of extra-
not cause translocation of PKC-a, PKC-d, or PKC-e in either cellular matrix proteins by mouse mesangial cells exposed
NG or HG. In HG, both basal and ET-1–stimulated MAPK
to advanced glycation end products is mediated throughactivities were increased significantly. In HG, down-regulation
a platelet-derived growth factor (PDGF)-B pathway [7].of PKC isoforms with phorbol ester prevented the increased
stimulation of MAPK by ET-1. PDGF-B stimulates the mitogen-activated protein kinase
Conclusion. In HG, the enhanced activation of mesangial (MAPK) cascade in mesangial cells [8], causing a mito-
cell MAPK by ET-1 is PKC dependent and associated with genic growth response [9], and is reported to activatealtered translocation of PKC-d and PKC-e. Enhanced mesan-
PKC-a, PKC-e, and PKC-z in mesangial cells [10, 11]gial cell signaling responsiveness to vasoactive peptides in HG
and PKC-a and PKC-b in vascular smooth muscle cellsmay constitute an important mechanism contributing to dia-
betic nephropathy. [12]. Nakamura et al have documented that endothelin-1
(ET-1) enhances and an ET-1 receptor A antagonist in-
hibits synthesis of extracellular matrix components and
Early diabetic nephropathy is characterized by rapid growth factors in diabetic glomeruli [13]. ET-1 stimulates
growth of glomerular and tubular structures [1]. It is now mesangial cell MAPK activity and subsequent c-fos induc-
tion, in part, via PKC [14, 15]. MAPK activity increased
by approximately 50% in mesangial cells cultured in highKey words: endothelin-1, platelet-derived growth factor-B, mitogen-
activated protein kinase, PKC, extracellular matrix. glucose for 48 hours [16] and in glomeruli isolated from
diabetic rats following two weeks of hyperglycemia [17].Received for publication June 19, 1998
These studies suggest a potential link between high glu-and in revised form August 28, 1998
Accepted for publication August 29, 1998 cose and enhanced activity of mesangial cell PKC and
MAPK in response to PDGF and ET-1. 1999 by the International Society of Nephrology
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Activation of PKC isoforms is associated with translo- Technologies, Mississauga, Ontario, Canada), 5 units/ml
insulin (GIBCO BRL), 100 units/ml penicillin-strepto-cation to different cellular compartments depending on
the specific isoform, the cell type, and the stimulus [18– mycin (GIBCO BRL), and 20% fetal bovine serum
(FBS; Wisent Inc., St.-Bruno, Quebec, Canada). Primary20]. The DAG-sensitive PKC isoforms identified consis-
tently in glomeruli and in primary cultured mesangial mesangial cells were identified by positive immunofluo-
rescence for the intermediate filaments desmin and vi-cells include PKC-a, PKC-d, and PKC-e [10, 16, 19, 21,
22]. Immunodetection of PKC-b and PKC-g is more mentin and were negative for cytokeratin and factor
VIII. The cells demonstrated a positive contractile re-controversial. Although Saxena et al recovered PKC-bI
and PKC-g from low-passage, growth-arrested mesan- sponse to ET-1 (Sigma Aldrich, Oakville, Ontario, Can-
ada). Mesangial cells from passages 8 to 10 were usedgial cells [23], to date the majority of investigators have
not detected these isoforms [16, 21, 24, 25]. DAG-sensi- for all experiments and were cultured to 90% confluence
in 100 3 20 mm dishes in Dulbecco’s modified Eagle’stive PKC isoforms sort into calcium-dependent (for ex-
ample, PKC-a, PKC-b, PKC-g) and calcium-indepen- medium (DMEM) containing 5.6 mm glucose, l-gluta-
mine, 110 mg/liter sodium pyruvate, prepared by thedent (PKC-d, PKC-e) subtypes [26]. Increased activity
of PKC-bI in the glomeruli of diabetic rats following two addition of 3.7 g/liter NaHCO3, 20 mm HEPES acid, and
20% FBS.weeks of high glucose was reported by Ishii et al [27].
In the heart and aorta of diabetic rats, PKC-bII is prefer-
Experimental protocolentially elevated along with increased DAG content [28].
In our laboratory, PKC-a, PKC-d, and PKC-e were found Prior to experimentation, the cells were growth-arrested
in DMEM containing 0.5% FBS and 5.6 or 30 mm glucosein growth-arrested primary rat mesangial cells of passage
less than 10 [29, 30] and also located by immunogold in for 48 hours, in the presence or absence of 1 mm phorbol
13-myristate 12-acetate (PMA), and were then serumthe mesangial cells of normal and diabetic rats in vivo [31].
The purpose of this study was to determine if high deprived for two hours. To determine the effects of high
glucose on mesangial cell PKC isoform translocation fol-glucose alters ET-1 or PDGF-B activation of mesangial
cell DAG-sensitive PKC isoforms and subsequent stimu- lowing agonist stimulation, a set of basal (unstimulated),
PMA-stimulated and agonist-stimulated cytosol, mem-lation of MAPK p42, p44. It was hypothesized that spe-
cific DAG-sensitive PKC isoforms translocate in re- brane or particulate fractions were analyzed together on
the same gel. The responses were compared with thesponse to ET-1 and PDGF-B and that in high glucose
activation of one or more PKC isoform is altered, leading basal, unstimulated condition in 5.6 mm glucose in each
experiment. Prior to harvest, serum-deprived cells in 5.6to enhanced stimulation of MAPK p42, p44. The condi-
tions of the study included serum deprivation of cultured mm or 30 mm glucose were stimulated with 10 or 100 nm
ET-1, 3 ng/ml PDGF-B (Boehringer Mannheim, Laval,rat mesangial cells (passages 8 to 10) to minimize the
influence of cell cycling and serum growth factors on the Quebec, Canada) or 100 nm PMA for 10 minutes at 378C.
The agonists were dissolved in DMEM (not less than 20activity of signaling enzymes. We examined PKC isoform
translocation from the cytosol to either the membrane ml) and pipetted directly into the medium to achieve the
final concentration.(Triton-X soluble) fraction or to the particulate [cy-
toskeleton/nucleus (sodium dodecyl sulfate-soluble)]
Cytosol, membrane and particulate fractionationfraction, to delineate possible changes in compartmental
distribution in high glucose. Under the same conditions, At the end of the 10 minute stimulation, the cells
were washed three times with phosphate buffered salineMAPK p42, p44 activation was analyzed by immunoblot
of phosphorylated MAPK and following immunoprecip- (PBS) at 48C and were scraped in 80 ml lysis buffer
containing 1 mm NaHCO3, 5 mm MgCl2, 50 mm Tris-HCl,itation of phospho-MAPK by the phosphorylation of
an Elk-1 fusion protein. Our data indicate that in high 2 mm ethylene glycol tetraacetic acid, 10 mm ethylene-
diaminetetraacetic acid (EDTA), 0.86 mm phenylmethyl-glucose, the compartmental distribution of specific PKC
isoforms is altered and that enhanced activation of sulfonylfluoride (PMSF), 25 mg/ml leupeptin, 10 mm ben-
zamidine, and 100 mm dithiothreitol (DTT; New EnglandMAPK by ET-1 in high glucose is PKC dependent.
Biolabs, Mississauga, Ontario, Canada). Fresh protease
inhibitors and DTT were prepared and added on the
METHODS
day of the experiment. The cell lysate (two to three plates)
Primary culture of rat glomerular mesangial cells was passed six times through a 26.5 inch gauge needle
(Becton Dickinson, Mississauga, Ontario, Canada).Mesangial cells were obtained from glomeruli of 200
g male Spague-Dawley rats as previously described [32]. After 30 minutes at 48C in the lysis buffer, the lysate
was centrifuged at 100,000 3 g at 48C to separate cytosolBriefly, glomeruli were isolated by selective sieving of
chopped renal cortex and initially plated in minimal es- (supernatant) from the pellet. For the membrane prepa-
ration, the pellets were washed with 30 ml lysis buffersential medium containing d-valine (GIBCO BRL, Life
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Fig. 1. (A) Representative paired immuno-
blots of mesangial cell PKC-a in the cytosol
and membrane fractions following 48 hours in
normal glucose (NG; 5.6 mM) or high glucose
(HG; 30 mM) and 10-minute stimulation with
phorbol 13-myristate 12-acetate (PMA; 100
nM), platelet-derived growth factor (PDGF-
B; 3 ng/ml), or endothelin-1 (ET-1; 100 nM).
The rat brain control PKC-a (1) was identified
as a single 82 kDa band identical to the mesan-
gial cell samples. (B) PKC-a immunoblot den-
sitometry data (mean 6 sem, N 5 5 experi-
ments) from mesangial cell cytosol and
membrane fractions are presented as percent-
age above normal glucose basal (100%). Sym-
bols are: (j) normal glucose; (h) high glucose
30 mm; *P , 0.05 vs. NG glucose basal; **P
, 0.01 vs. NG basal. (C) In mesangial cells,
cytosol and membrane-associated PKC-a was
down-regulated with phorbol 13-myristate 12-
acetate (PMA; 1 mm) for 48 hours in normal
(5.6 mm) or high (30 mm) glucose followed
by stimulation with acute PMA 100 nm or
endothelin-1 (ET-1; 100 nm). Rat brain was
used as positive control (1).
and solubilized in 100 to 170 ml lysis buffer at 48C con- discarded. For the isolation of the particulate fraction,
following the initial centrifugation, the pellet was solubi-taining 10 ml/ml Triton-X-100 (BDH, Toronto, Ontario,
Canada) by passing through a 26.5 inch gauge needle. lized in 250 to 300 ml lysis buffer at room temperature
containing 10 ml/ml Triton-X-100 and 2% sodium dode-After a second centrifugation at 100,000 3 g at 48C, the
membrane (supernatant) fractions were placed on ice, cyl sulfate (SDS) and passed first through a six inch
gauge then a 26.5 inch gauge needle followed by filtrationand the remaining fractions (Triton-X insoluble) were
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After transfer, the membrane was rinsed with H2O
and blocked with 5% skim milk powder in Tris-buffered
saline, pH 8.0, containing 0.05% Tween-20 (TTBS), for
four hours with slow shaking at room temperature. The
blocking solution for analysis of the particulate samples
also contained 5% BSA, fraction V (ICN Pharmaceuti-
cals). After rinsing in H2O, the membrane was incubated
in a 1:500 dilution (0.5 mg/ml) of primary monoclonal
antibody (Transduction Labs, Mississauga, Ontario,
Canada) for PKC-a, PKC-d, or PKC-e, or polyclonal
antibody for PKC-a (Sigma Chemical Co., St. Louis,
MO, USA) in TTBS 1 5% skim milk for one hour at
room temperature. The membrane was washed three
times (five min) with TTBS and was then incubated for
20 minutes at room temperature with slow shaking in a
1:5000 dilution (TTBS 1 5% skim milk) of horseradish
peroxidase (HRP)-labeled secondary goat antimouse
IgG (BioCan Scientific, Mississauga, Ontario, Canada)
to detect primary monoclonal antibodies or goat antirab-
bit IgG (Bio-Rad) to detect polyclonal antibodies. The
blots were washed three times (seven min) with TTBS
and once (10 min) with TBS.
Uniform loading of protein in each lane was confirmedFig. 2. (Upper panel) Representative paired immunoblots of mesangial
cell PKC-a in the cytosol and particulate fractions following 48 hours by staining the membrane with Ponceau S (Sigma). The
in normal glucose (NG; 5.6 mM) or high glucose (HG; 30 mM) and 10- secondary antibodies were visualized using enhancedminute stimulation with phorbol 13-myristate 12-acetate (PMA; 100
chemiluminescence (Kirgegaard & Perry LaboratoriesnM) or endothelin-1 (ET-1; 100 nM). Rat brain control (1) was used as
a positive control. (Lower panel) PKC-a immunoblot densitometry data Inc., Gaithersburg, MD, USA). The blot was exposed
(mean 6 sem, N 5 5 experiments) from mesangial cell cytosol (h) and
to Kodak X-omat film (Kodak, Toronto, Ontario, Can-particulate fractions (j) are presented as percentage above NG basal
(100%). *P , 0.05 vs. NG basal. ada) for one minute. Densitometry was performed with a
Macintosh gel photodocumentation system (ImageStore
5000; Ultraviolet Products, San Gabriel, CA, USA) using
a white-light transilluminator. The area under each peakthrough disposable, large-pore filters (Wheaton, Mill-
of the intensity curve was analyzed (arbitrary units) usingville, NJ, USA) to remove the insoluble DNA. All cyto-
NIH Image software (version 1.62; National Institutessol, membrane and particulate fraction samples were
of Health, Bethesda, MD, USA) for the Macintosh. Dataassayed for protein in quadruplicate using the modified
from five separate experiments were pooled to analyzemicro Lowry protein assay (Bio Rad Dc Assay Kit; Bio- each PKC isoform. All results were expressed as a ratioRad, Mississauga, Ontario, Canada) with bovine serum
compared with 5.6 mm glucose. Immunoblot densitiesalbumin (BSA; ICN Pharmaceuticals, Montreal, Quebec,
from the same gel were compared, and the percentageCanada) as the standard. Each sample was added to one-
of normal glucose basal values was pooled for statisticalthird volume of 4 3 Laemmli sample buffer (0.260 m
analysis.Tris-base, pH 6.8 with HCl, 4% b-mercaptoethanol, 8%
SDS, 40% glycerol, 0.04% bromophenol blue), boiled Immunofluorescence labeling of PKC isoforms and
for two minutes, and stored at 2208C.
confocal microscopy
Protein kinase C isoform immunoblotting Mesangial cells were cultured on glass cover slips and
were treated as described earlier here. The cells wereEqual amounts of protein (15 mg) from each sample
fixed with 3.7% formaldehyde for 15 minutes at roomand rat brain PKC-positive control were separated by
temperature followed by plasma membrane and nuclearsodium dodecyl sulfate-polyacrylamide gel electrophore-
membrane permeabilization with 100% methanol atsis (SDS-PAGE; 10% polyacrylamide) at 100 V for two
2208C for 10 minutes. After washing three times withhours. The gel was equilibrated in transfer buffer at room
PBS, the cell proteins were blocked with 1% goat serumtemperature, and the proteins were transferred to PVDF
plus 0.1% BSA in PBS for 60 minutes at room tempera-Immobilon hydrophobic membranes (Millipore, Bedford,
ture. Mouse monoclonal anti-PKC-d or PKC-e antibod-MA, USA) overnight at 48C in transfer buffer (25 mm
Tris-base, 192 mm glycine, pH 8.3, plus 20% methanol). ies were diluted to 1:100 in blocking solution and added
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Fig. 3. (A) Representative paired immunoblots of mesangial cell
PKC-d in the cytosol and membrane fractions following 48 hours in
normal glucose (NG; 5.6 mM) or high glucose (HG; 30 mM) and 10-
minute stimulation with phorbol 13-myristate 12-acetate (PMA; 100
nM), platelet-derived growth factor-B (PDGF-B; 3 ng/ml), or endo-
thelin-1 (ET-1; 100 nM) are presented. The rat brain control PKC-d (1)
was identified as a single 78 kDa band identical to the mesangial cell
samples. (B) PKC-d immunoblot densitometry data (mean 6 se, N 5 5
experiments) from mesangial cell cytosol and membrane fractions are
presented as percentage above NG basal (100%). Symbols are: (j)
normal glucose (NG); (h) high glucose 30 mm; *P , 0.05 vs. NG basal;
**P , 0.01 vs. NG basal; §P , 0.05 vs. HG basal. (C) In mesangial
cells, cytosol and membrane-associated PKC-d was down-regulated with
phorbol 13-myristate 12-acetate (PMA; 1 mm) for 48 hours in normal
glucose (NG; 5.6 mm) or high glucose (HG; 30 mm) followed by stimula-
tion with acute phorbol 13-myristate 12-acetate (PMA; 100 nm) or endo-
thelin-1 (ET-1; 100 nm). Rat brain was used as a positive control (1).
to each cover slip for 60 minutes at 378C. After washing and 520 nm, respectively. The cells were visualized with
an oil-immersion inverted objective lens (Axiovert 100,three times with PBS, the FITC-conjugated secondary
antibody (Molecular Probes Inc., Eugene, OR, USA) 363), and the image pixel resolution was 512 3 512 with
a gray level scale of 0 (minimum) to 255 (maximum)diluted 1:160 in blocking solution was added for 60 min-
utes at 378C in the dark, and was then washed and intensity. To standardize the fluorescence intensity for
all of the experimental preparations, the confocal imagemounted on glass slides with Aqua-Poly mount (Poly-
sciences, Inc., Warrington, PA, USA) and Slowfade re- contrast and brightness levels were adjusted optimally
for each PKC isoform and were then kept constant. Theagent (Molecular Probes). The FITC-labeled PKC iso-
forms were imaged using a confocal laser scanning image pinhole (size 5 20), scanning time (0.546 seconds), and
magnification (63 3 1.4) of the confocal scanning systemsystem (LSM 410; Zeiss, Du¨sseldorf, Germany) with
FITC excitation and emission wavelengths of 488 nm were constant for all image analysis. Incubation with
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natant was removed and assayed for protein using the
modified micro-Lowry method. One-third volume of 4 3
Laemmli sample buffer was added, and the sample was
boiled for two minutes followed by storage at 2208C
until immunoblotting.
The SDS-PAGE, transfer and blocking were per-
formed identically as described for the PKC isoform
immunoblot (earlier here). A molecular weight standard
sample (New England Biolabs) was also loaded on each
gel to verify the molecular size of each band. After wash-
ing, the membrane was exposed to 1:3000 dilution of
affinity-purified rabbit polyclonal IgG phospho-specific
MAPK antibody (New England Biolabs) in TTBS 1 5%
BSA overnight at 48C with slow shaking. This antibody
detects p42 and p44 MAPK when catalytically activated
by phosphorylation at both Thr 202 and Tyr 204. It does
not cross-react with phosphorylated stress-activated pro-
tein kinase or p38 MAPK homologues. To test the speci-
ficity of the phospho-specific antibody, negative and posi-
tive phospho-MAPK control samples were loaded on
each gel. The negative control was a kinase-inactive p42
protein (New England Biolabs), and the positive control
was a fully phosphorylated (by MAPK kinase) p42 pro-
Fig. 4. (Upper panel) Representative paired immunoblots of mesangial tein purified free from nonphosphorylated MAPK (New
cell PKC-d in the cytosol and particulate fractions following 48 hours
England Biolabs).in normal glucose (NG; 5.6 mM) or high glucose (HG; 30 mM) and 10-
minute stimulation with phorbol 13-myristate 12-acetate (PMA; 100 nM) After washing briefly in H2O, the membranes were
or endothelin-1 (ET-1; 100 nM). Rat brain was used as a positive control. washed three times (five minutes) at room temperature
(Lower panel) PKC-d immunoblot densitometry data (mean 6 se, N 5 5
in TTBS with vigorous shaking, followed by exposureexperiments) from mesangial cell cytosol (h) and particulate (j) frac-
tions presented as percentage above NG basal (100%). *P , 0.05 vs. to a 1:5000 dilution of HRP-conjugated antirabbit sec-
NG basal; **P , 0.05 vs. NG 1 ET-1. ondary antibody (Bio-Rad) for 20 minutes at room tem-
perature with gentle shaking. The blots were washed and
detected as described earlier here.
The same membranes were used to detect total MAPK
FITC-conjugated secondary antibody alone demon- protein. To extinguish the chemiluminescence reaction
strated no significant labeling. without stripping the protein, the membrane was ex-
posed to 15% peroxide for 15 minutes at room tempera-Analysis of MAPK activation
ture, with gentle shaking. After a five-minute wash, the
Phosphorylation of MAPK analyzed by immunoblot. membrane was reblocked, and the immunoblot was re-
The effect of high glucose exposure for 2.5, 6, 12, 24, peated using anti-MAPK IgG (mouse) monoclonal anti-
and 48 hours on MAPK phosphorylation was analyzed. body (Transduction Labs), which reacts with both p42
After 48 hours in normal and high glucose, stimulation and p44, detecting both nonphosphorylated and phos-
with ET-1 10 nm or PDGF-B 3 ng/ml for 10 minutes was phorylated MAPK. This was followed by HRP-conju-
performed as described earlier here for the PKC isoform gated secondary antibody (antimouse), which does not
translocation studies. cross-react with the original antiphosphorylated MAPK
Following agonist stimulation, the cells were washed IgG (rabbit). Densitometry was performed on both sets
three times in PBS at 48C and scraped on ice with a of blots, and the results were expressed as a ratio of
rubber spatula in 80 ml lysis buffer [50 mm Tris HCl, pH phospho-MAPK to total MAPK, to control for differ-
7.4, 150 mm NaCl, 1 mm EGTA, 1% Nonidet P-40 ences in the amounts of cellular MAPK. Data from four
(BDH), 0.25% sodium deoxycholate (Sigma), 1 mm separate experiments were pooled for statistical analysis.
PMSF, 1 mg/ml aprotinin (Sigma), 1 mg/ml leupeptin, 1 Elk-1 fusion protein phosphorylation following phos-
mg/ml pepstatin (Sigma), 1 mm orthovanadate, 1 mm pho-MAPK immunoprecipitation. Following agonist stim-
NaF]. The lysate was then passed through a 26.5 inch ulation as described earlier here, the cells were rinsed
needle four times and incubated at 48C for 20 minutes. once with ice-cold PBS. Then lysis buffer containing 20
The remaining particulate content was removed with a mm Tris (pH 7.5), 150 mm NaCl, 1 mm EDTA, 1 mm
EGTA, 1% Triton, 2.5 mm sodium pyrophosphate, 1 mm10-minute centrifugation at 10,000 3 g, 48C. The super-
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b-glycerolphosphate, 1 mm Na3VO4, 1 mg/ml leupeptin,
and 1 mm PMSF was added, and the plates were left on
ice for five minutes. The cells were scraped off the plate,
sonicated (four times for five seconds), and microcentri-
fuged for 10 minutes at 48C, and the supernatant was
collected and assayed for protein using the modified mi-
cro-Lowry protein method. To immunoprecipitate active
MAPK, phospho-specific MAPK p42, p44 monoclonal
antibody (1:400 dilution, New England Biolabs) was
added to each 200 mg sample protein. After overnight
incubation at 48C, protein A sepharose beads were added
and incubated for three hours at 48C. The immunoprecip-
itates were then microcentrifuged for 30 seconds at 48C.
The pellets were washed twice with lysis buffer and twice
with kinase buffer containing 25 mm Tris (pH 7.5), 5 mm
b-glycerolphosphate, 2 mm DTT, 0.1 mm Na3VO4, 10 mm
MgCl2, suspended in 50 ml kinase buffer supplemented
with 200 mm adenosine triphosphate and 2 mg Elk-1 fu-
sion protein followed by incubation for 30 minutes at Fig. 5. PKC-d immunofluorescence. Mesangial cells growth-arrested
on glass cover slips were cultured in normal (5.6 mm) glucose or high308C. The reaction was terminated with the addition of
(30 mm) glucose for 48 hours, followed by 10 minutes of stimulation25 ml of 3 3 SDS sample buffer. The samples were with endothelin-1 (ET-1; 100 nm). PKC-d was detected in fixed, perme-
boiled for five minutes, vortexed, and microcentrifuged. abilized cells by confocal scanning immunofluorescence microscopy us-
ing monoclonal anti-PKC–d antibody and FITC-conjugated secondaryImmunoblotting was performed as described earlier here
antibody (magnification 3240).using 12% SDS-PAGE. After blocking with TTBS con-
taining 5% skim milk for three hours at room tempera-
ture, the membrane was incubated with phospho-specific
Elk-1 antibody (1:2000 dilution) overnight at 48C. Active with the rat brain positive control. No difference in the
MAPK (New England Biolabs) was used as a positive basal (unstimulated) cytosol or membrane fractions was
control. Elk-1 fusion protein phosphorylation was de- observed in high glucose compared with the low glucose
tected with the enhanced chemiluminescence method, and condition (Fig. 1 A, B). PMA stimulated translocation
densitometry was performed as described earlier here. of PKC-a from the cytosol to membrane fraction in both
normal and high glucose. No significant translocationStatistical analysis
was observed when the cells were stimulated with ET-1All final densitometric ratio data were expressed as
or PDGF in either normal or high glucose. In a separatemean 6 standard error (se). Statistical analysis was per-
experiment, during 48 hours of exposure to 1 mm PMA,formed using InStat software (version 2.01; Graph Pad
PKC-a disappeared from both the cytosol and mem-Software, Sacramento, CA, USA) for Macintosh. To
brane fractions, indicating down-regulation (Fig. 1C).compare the translocation from cytosol-to-membrane
In the particulate fractions (Fig. 2), the same 82 kDaand cytosol-to-particulate results, one-way analysis of
band was observed, and PMA stimulated translocationvariance for unpaired samples was performed. To com-
from the cytosol to the particulate fractions. No translo-pare all conditions with basal NG, the Dunnett multiple
cation from the cytosol-to-particulate fraction was stimu-comparisons was used. To compare other selected data,
lated by ET-1 (Fig. 2) or PDGF-B (data not shown).an unpaired, two-tailed Student t-test was used.
PKC-d
RESULTS In the cytosol and membrane fractions, a single band
Effect of high glucose on PKC isoform translocation of 78 kDa was observed (Fig. 3A), which comigrated
in response to PMA, ET-1, and PDGF with the positive control. In basal (unstimulated) high
glucose, a significant increase in the membrane fractionThe recovery of total mesangial cellular protein from
(P , 0.01 vs. normal glucose basal), but no change in thethe 100 mm culture plates was no different in 30 mm
cytosol fraction, was observed (Fig. 3 A, B). PMA andglucose compared with 5 mm glucose, 2.48 6 0.17 mg/ml
ET-1 stimulated a significant decrease in the cytosol inand 2.53 6 0.18 mg/ml, respectively.
both normal and high glucose. In normal glucose, PMA
PKC-a and ET-1 stimulated a significant increase in the mem-
brane fraction. By contrast, in high glucose, the mem-In the cytosol and membrane fractions, a single band
of 82 kDa was observed (Fig. 1A), which comigrated brane-associated PKC-d declined below the basal level.
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Fig. 6. (A) Representative paired immunoblots of mesangial cell PKC-
e in the cytosol and membrane fractions following 48 hours in normal
glucose (NG; 5.6 mM) or high glucose (HG; 30 mM) and 10 minutes
of stimulation with phorbol 13-myristate 12-acetate (PMA; 100 nM),
platelet-derived growth factor (PDGF-B; 3 ng/ml), or endothelin-1 (ET-
1; 100 nM). The rat brain control PKC-e (1) was identified as a single
90 kDa band identical to the mesangial cell samples. (B) PKC-e immu-
noblot densitometry data (mean 6 se, N 5 5 experiments) from mesan-
gial cell cytosol and membrane fractions were compared with basal
(unstimulated) normal glucose (5.6 mm; NG) and are presented as
percentage above NG basal (100%). Symbols are: (j) normal glucose;
(h) high glucose 30 mm; **P , 0.01 vs. NG basal; §NS vs. HG basal.
(C) In mesangial cells, cytosol and membrane-associated PKC-e was
down-regulated with phorbol 13-myristate 12-acetate (PMA; 1 mm) for
48 hours in normal (5.6 mm; NG) or high (30 mm; HG) glucose, followed
by stimulation with acute PMA 100 nm or endothelin-1 (ET-1; 100 nm).
Rat brain was used as a positive control (1).
PDGF-B stimulation caused no translocation of PKC-d. mary monoclonal antibody to PKC-d are shown in Figure
5. In normal glucose, PKC-d was distributed throughoutChronic exposure to PMA down-regulated PKC-d in
both the cytosol and membrane fractions (Fig. 3C). PKC-d the cytosol, and in the presence of ET-1, increased
PKC-d label was observed particularly at plasma mem-was observed in the particulate fraction at 78 kDa. In
brane locations. In high glucose, increased fluorescencenormal glucose, PMA and ET-1 caused a significant de-
and plasma membrane highlights were observed in thecline in cytosol but no change in the particulate fraction
basal state, and a further change in intensity and nuclear(Fig. 4). In high glucose, translocation to the particulate
localization was observed in high glucose plus ET-1.fraction stimulated by ET-1 was increased significantly
(P , 0.05 vs. 5.6 mm glucose plus ET-1). PDGF-B caused
PKC-eno translocation to the particulate fraction (data not
shown). In the cytosol and membrane fractions, PKC-e was
observed as a single band of 90 kDa that comigratedRepresentative confocal immunofluorescence images
cut through the mesangial cell nucleus labeled with pri- with the positive control, as demonstrated in Figure 6.
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Fig. 8. PKC-e immunofluorescence. Mesangial cells growth arrested
on glass cover slips were cultured in normal (5.6 mm) glucose or high
(30 mm) glucose for 48 hours, followed by a 10-minute stimulation with
endothelin-1 (ET-1; 100 nm). PKC-e was detected in fixed, permeabil-
ized cells by confocal scanning immunofluorescence microscopy using
monoclonal anti–PKC-e antibody and FITC-conjugated secondary anti-
body (magnification 3240).
Fig. 7. (Upper panel) Representative paired immunoblots of mesangial
cell PKC-e in the cytosol and particulate fractions following 48 hours
in normal glucose (NG; 5.6 mM) or high glucose (HG; 30 mM) and 10-
minute stimulation with phorbol 13-myristate 12-acetate (PMA; 100
nM) or endothelin-1 (ET-1; 100 nM) are illustrated. (Lower panel) PKC-d mary monoclonal antibody to PKC-e are shown in Figure
immunoblot densitometry data (mean 6 se, N 5 5 experiments) from 8. In the normal glucose basal state, PKC-e was distrib-
mesangial cell cytosol (h) and particulate (j) fractions are presented
uted throughout the cytoplasm. In the presence of ET-1,as percentage above NG basal (100%). *P , 0.05 vs. NG basal; **P ,
0.05 vs. NG 1 ET-1. increased intensity and translocation to the nucleus were
observed. In high glucose, increased intensity within the
cytoplasm, including a cytoskeletal distribution and nu-
clear labeling of PKC-e, was apparent. In high glucose,
In high glucose, a significant increase in membrane-asso- the addition of ET-1 caused redistribution of PKD-e into
ciated PKC-e was observed (P , 0.05 vs. 5.6 mm glucose a filamentous pattern.
basal). No change in cytosolic PKC-e was apparent in
high glucose. PMA and ET-1 stimulated a very significant MAPK activation in high glucose and
in response to PMA, ET-1, and PDGF-Btranslocation of PKC-e from the cytosol to the mem-
brane fractions in both normal and high glucose (Fig. 6 There was a time-dependent phosphorylation of MAPK
A, B). In high glucose, after ET-1 stimulation, there on exposure of the mesangial cells to high glucose over
was a proportionately smaller increase in the membrane- 48 hours, as assessed by immunoblotting of phospho-
associated PKC-e despite a decrease in cytosol content MAPK. The increase in phosphorylation was observed
similar to that observed in normal glucose (Fig. 6 A, B). between 24 and 48 hours. The total cellular content of
PDGF-B did not cause translocation of PKC-e. Chronic MAPK was unchanged, whereas the phospho-MAPK/
exposure to PMA down-regulated PKC-e in both the total MAPK (p42 plus p44) increased to 1.5- 6 0.3-fold
cytosol and membrane fractions (Fig. 6C). above the 5.6 mm glucose value (P , 0.05, N 5 5).
Protein kinase C-e was observed in the particulate In response to acute PMA, PDGF or ET-1 increase
fraction as a single 90 kDa band (Fig. 7). In normal in phospho-MAPK occurred as early as five minutes and
glucose, PMA and ET-1 stimulated a significant decrease was no different at 10, 15, or 30 minutes (data not shown).
in the cytosol content, with no change in the particulate Figure 9 illustrates that acute exposure to PMA, or
fraction. In high-glucose, ET-1 stimulation was associ- PDGF-B augmented the amount of phospho-MAPK in
ated with a significant increase of PKC-e in the particu- mesangial cells similarly in normal and high glucose.
late fraction (P , 0.05 vs. 5.6 mm glucose plus ET-1). Chronic exposure to PMA, which down-regulated PKC,
Representative confocal immunofluorescence images abolished the response to acute re-exposure to PMA but
did not alter the response to PDGF-B (N 5 5).cut through the mesangial cell nucleus labeled with pri-
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Fig. 9. Mitogen-activated protein kinase
(MAPK) activation by platelet-derived growth
factor (PDGF)-B. Growth-arrested cells were
cultured in normal glucose (NG; 5.6 mm) or
high glucose (HG; 30 mm) in the presence
or absence of phorbol 13-myristate 12-acetate
(PMA; 1 mm) for 48 hours followed by two
hours of serum-deprivation. Cells in NG, NG 1
PMA (chronic), and HG were stimulated with
acute PMA 100 nm for 10 minutes. Cells in
NG, NG 1 PMA (48 hr), HG, and HG 1 PMA
(48 hr) were stimulated with PDGF-B 3 ng/
ml for 10 minutes. In the same mesangial cell
total lysates, anti-phospho-MAPK antibody
(P, upper blot) or anti-MAPK antibody (T,
lower blot) were used to detect phosphorylated
and total MAPK, respectively. A negative (2)
phospho-MAPK and positive (1) phospho-
MAPK are included in the upper blot. *P ,
0.05 vs. NG basal, N 5 5 experiments.
Figure 10 illustrates that acute exposure to ET-1 10 nucleus and perinuclear area (Fig. 8). Increased intensity
nm also stimulated an increase in phospho-MAPK. In of PKC isoform immunofluorescence is associated with
contrast to PDGF-B, the response to ET-1 in high glu- activation, as previously reported [19, 33]. In the high-
cose was significantly greater than that in normal glucose glucose basal condition, immunoblot analysis revealed
(P , 0.05, N 5 5). Furthermore, chronic exposure to an increased proportion of PKC-d and PKC-e in the
PMA diminished this enhanced activation such that the membrane fraction. The immunofluorescence patterns
responses to ET-1 in normal and high glucose were no of mesangial cell PKC-d and PKC-e after 48 hours of
longer different. high glucose resembled the patterns in normal glucose
To further identify the activation of MAPK, following following ET-1 stimulation. In high glucose, following
immunoprecipitation of activated MAPK with phospho- ET-1 stimulation, immunoblotting demonstrated a change
MAPK antibody from total cell lysate, phosphorylation in the translocation pattern of both PKC-d and PKC-e
of Elk-1 fusion protein was examined. As illustrated in to a cytosol-to-particulate distribution. Immunofluores-
Figure 11, in high-glucose, ET-1 10 nm stimulated MAPK cence imaging indicated that in high glucose, ET-1 stimu-
activity significantly above that observed in normal glu- lated translocation of PKC-d to the nucleus, and PKC-e
cose. Preincubation with PMA diminished this enhanced became localized to the nucleus and cytoskeleton com-
activation, returning the level to that observed during partment. Taken together, the immunoblot and immuno-
mesangial cell stimulation by ET-1 in normal glucose. fluorescence data suggest that high glucose causes an
increase in membrane-associated PKC-d and PKC-e. ET-1
stimulates both PKC-d and PKC-e, and in high glucose,DISCUSSION
the pattern of translocation is altered from a predomi-Mesangial cells express the DAG-sensitive PKC iso-
nantly cytosol-to-membrane distribution to a cytosol-to-forms -a, -d, and -e. In normal glucose, ET-1 stimulation
particulate (cytoskeleton/nucleus) pattern.caused cytosol-to-membrane translocation of PKC-d and
We found that basal MAPK activity is increased in highPKC-e but no translocation to the particulate fraction.
glucose as reported previously in cultured mesangial cellsPDGF-B caused no translocation of these PKC isoforms.
and glomeruli isolated from diabetic rats [17]. A rise inConfocal immunofluorescence imaging revealed that
activity was observed between 24 and 48 hours of exposureET-1 caused translocation of PKC-d to peripheral mem-
brane sites (Fig. 5) and redistribution of PKC-e to the to high glucose, without an alteration in total MAPK.
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Fig. 10. Mitogen-activated protein kinase
(MAPK) p42, p44 phosphorylation following
endothelin-1 (ET-1) stimulation. Growth-
arrested cells were cultured in normal glucose
(NG; 5.6 mm) or high glucose (HG; 30 mm) in
the presence or absence of phorbol 13-myri-
state 12-acetate (PMA; 1 mm) for 48 hours
followed by two hours of serum deprivation.
Cells in NG, NG 1 PMA (chronic), and HG
were stimulated for 10 minutes with acute PMA
100 nm for 10 minutes. Cells in NG, NG 1
PMA (48 hr), HG, and HG 1 PMA (48 hr)
were stimulated with ET-1 (10 nm) for 10 min-
utes. In the same mesangial cell total lysates,
anti-phospho-MAPK antibody (P, upper blot)
or anti-MAPK antibody (T, lower blot) were
used to detect phosphorylated and total
MAPK, respectively. A negative (2) phospho-
MAPK and positive (1) phospho-MAPK, as
described in the Methods section, are included
in the upper blot. A total MAPK positive con-
trol is shown in the lower immunoblot panel.
*P , 0.05 vs. NG basal; **P , 0.05 vs. NG
basal; §P , 0.05 vs. NG 1 ET-1; §§P , 0.05
vs. HG 1 ET-1; N 5 5 experiments.
PMA, ET-1, and PDGF all activated MAPK p42, p44, as be due to differences in cellular fraction isolation or to
the timing of analysis following exposure to high glucosedemonstrated by the appearance of increased phospho-
MAPK and enhanced phosphorylation of Elk-1 fusion or to both. We have previously observed that in high
glucose, the increase in mesangial cell total and mem-protein. In high glucose, phosphorylation of MAPK p42,
p44 following PDGF-B was unchanged, whereas ET-1 10 brane-associated PKC-d and PKC-e occurs between 24
and 48 hours [29, 30]. Our immunoblot finding of in-nm stimulation caused a significant increase in phospho-
MAPK. When the DAG-sensitive PKC isoforms were creased mesangial cell membrane-associated PKC-d and
PKC-e following 48 hours of high glucose is consistentdown-regulated during chronic exposure to PMA, ET-1–
dependent MAPK activation was no different in high with increased activity [31], although a coincident de-
crease in cytosol content was not observed. This may beglucose compared with the normal glucose condition
(Fig. 11). These data suggest that in high glucose, the explained by an increase in total amount of cellular
PKC-d and PKC-e in high glucose. Then, during a smallenhanced MAPK activation is mediated by a DAG-sensi-
tive PKC pathway. The altered pattern of ET-1–stimu- amount of translocation, no apparent decrease in basal
cytosolic content would be observed compared with nor-lated PKC-d and PKC-e translocation may contribute to
enhanced MAPK activation. mal glucose. Although the confocal images illustrate a
definite change caused by high glucose of immunofluo-Our finding of increased membrane association and
altered immunofluorescence patterns of PKC-d and rescence intensity and probable translocation of PKC-d
and PKC-e in the basal state, these data cannot distin-PKC-e in the presence of high glucose is in keeping with
the report of Haller et al [33], who demonstrated in guish between increased amount of PKC isoform in asso-
ciation with a pattern of activation/translocation in highvascular smooth muscle cells, by immunoblot and confo-
cal microscopy, the translocation of PKC-a, PKC-b, glucose [19]. A more detailed study examining the time-
dependent effects of high glucose on total cellular con-PKC-d, and PKC-e within 6 to 12 hours of exposure to
high glucose. However, in cultured rat mesangial cells tent of each PKC isoform is required to address this
important question adequately.after three to five days of high glucose, Kikkawa et al
reported enhanced recovery of membrane-associated The finding that high glucose alters the translocation
pattern of PKC-d and PKC-e in response to ET-1 isPKC-a and PKC-z, but not PKC-d and PKC-e [34]. The
differences between the latter study and our own may novel. The work of Mochly-Rosen et al indicates that
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activation of MAPK suggests that any contribution of
PKC-z is either minimal or unaltered under these condi-
tions.
In normal glucose, ET-1 stimulates MAPK principally
through a PKC-independent pathway, including p21ras
[39]. In high glucose, the increased MAPK phosphoryla-
tion caused by ET-1 appeared to be entirely PKC depen-
dent. Thus, our data indicate that in high glucose, the
PKC-dependent pathway stimulated by ET-1, involving
PKC-d and PKC-e, is altered. The increased membrane
content of PKC-d and PKC-e in high glucose alone and
the altered translocation pattern by ET-1 in the presence
of high glucose are both associated with enhanced
MAPK activation. The link between PKC and the
MAPK pathway may be at the level of Raf (a MAPK
kinase kinase), which may be directly phosphorylated
and activated by DAG-sensitive PKC [40, 41]. Raf is
known to bind not only to membrane but also to cy-
toskeletal elements to become activated [42]. We specu-
late that in high glucose, the increased membrane recov-
Fig. 11. Elk-1 fusion protein phosphorylation. Growth-arrested mesan- ery and, after ET-1 stimulation, particulate localization
gial cells were cultured in normal glucose (NG; 5.6 mm) or high glucose
of PKC-d and PKC-e enhance the activity of Raf and,(HG; 30 mm) in the presence or absence of phorbol 13-myristate 12-
acetate (PMA; 1 mm) for 48 hours and were then serum deprived for in turn, MAPK kinase. Alternatively, PKC may influence
two hours. Cells were then stimulated for 10 minutes with ET-1 10 nm, MAPK-specific phosphatases [43, 44], resulting in in-
and total cell lysate was immunoprecipitated with anti-phospho-MAPK
creased MAPK activity. Phorbol esters increase the ac-antibody. The activity of MAPK p42, p44 was observed using Elk-1
fusion protein as the substrate for phosphorylation that was detected tivity of some protein tyrosine phosphatases by phos-
with antiphospho-Elk-1 antibody. A representative immunoblot is dem- phorylation at specific serine residues [45, 46]. Further
onstrated (N 5 3 experiments).
analysis of the intermediate signaling steps is required
to define the molecular mechanisms of high glucose on
PKC-activation of MAPK.
These data demonstrate that normal mesangial cellindividual PKC isoforms are anchored to different sub-
cellular structures, for example, cytoskeleton, via specific signaling pathways, for example, ET-1, may be altered
in the presence of a high-glucose environment. The no-receptors for activated C kinase (RACKs) [35, 36].
RACKs are not PKC substrates, but enable PKC iso- tion that normal physiological stimuli lead to abnormal
responses in the diabetic milieu provides a potentiallyforms to colocalize with their substrates, thus facilitating
phosphorylation. PKC-a, PKC-d, and PKC-e may bind unifying mechanism linking many factors that appear
to contribute to progressive diabetic glomerulosclerosis.to cytoskeletal structures, as demonstrated in a wide
variety of mammalian cell types, including rat pituitary Our work has focused on the early effects of high glucose.
Prolonged exposure to elevated glucose or to recurrentcells [37] and neurons [38]. One explanation for our
finding of increased translocation of PKC-d and PKC-e changes in plasma glucose levels in the diabetic state
may lead to altered acute responses and gene expressionto the particulate fraction in high glucose following ET-1
stimulation may be an alteration in the expression or stimulated by vasoactive peptides, growth factors, and
cytokines. MAPK is a final common pathway for manyfunction of RACKs specific for these isoforms. Perhaps
the increased membrane association of PKC-d and PKC-e extracellular signals in mammalian cells [47–49]. Specific
MAPK substrates include p90rsk, phospholipase A2, cald-in high glucose in the basal state precludes translocation
from the cytosol to the membrane sites following ET-1 esmon, c-jun, and c-myc [50, 51]. AP-1 is activated by
c-fos expression due to increased phosphorylation bystimulation.
In growth-arrested mesangial cells, activation of MAPK of the ternary complex factor Elk-1 and serum
response factor [52]. In the pathogenesis of diabetic ne-DAG-sensitive PKC isoforms with PMA caused a dra-
matic increase in MAPK phosphorylation, equivalent to phropathy, increased mesangial cell growth [1, 2, 8, 13],
enhanced expression of transforming growth factor-b1PDGF-B stimulation of MAPK phosphorylation, which
was PKC independent. PDGF-B may signal, in part, [1, 53, 54], and extracellular matrix protein synthesis [54,
55] may be downstream events that respond to activatedthrough DAG-insensitive PKC-z, which is expressed in
rat mesangial cells [22], and possibly altered in high glu- MAPK [16, 17]. Thus, selective inhibition of this key
signaling pathway in organs targeted for diabetic compli-cose [34]. The lack of effect of high glucose on PDGF-B
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